Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: A pilot randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 2, 2004, Pages 148-153

  Grimes, David A ^a   Smith, M Susan ^a   Witham, Angela D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; BIOSAFETY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; GESTATION PERIOD; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MENSTRUAL CYCLE; METHODOLOGY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PAIN; PATIENT CARE; PATIENT SATISFACTION; PILOT STUDY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; UTERINE CERVIX DILATATION; UTERUS SURGERY; VOMITING;

EID: 0442307689     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2003.00044.x-i1     Document Type: Article

References (25)

1. Cates Jr W, Schulz KF, Grimes DA, et al. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting. JAMA 1982;248:559-563.
2. Grimes DA, Schulz KF, Cates Jr W, Tyler Jr CW. Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med 1977;296:1141-1145.
3. Grimes DA, Hulka JF, McCutchen ME. Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2 alpha: a randomized clinical trial. Am J Obstet Gynecol 1980;137:785-790.
4. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 2002;187:393-397.
5. Royal College of Obstetricians and Gynaecologists. National Evidence-Based Clinical Guidelines. The Care of Women Requesting Abortion. Available at: http://www.rcog.org.uk/guidelines.asp?PageID=108&Type= guidelines&GuidelinesID=31. Accessed: November 21, 2003.
6. Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106:706-710.
7. Binkin NJ, Schulz KF, Grimes DA, Cates Jr W. Urea-prostaglandin versus hypertonic saline for instillation abortion. Am J Obstet Gynecol 1983;146:947-952.
8. Herndon J, Strauss LT, Whitehead S, Parker WY, Bartlett L, Zane S. Abortion surveillance - United States, 1998. Morb Mortal Wkly Rep Surveill Summ 2002;51:1-32.
9. Hadlock FP, Deter RL, Harrist RB, Park SK. Fetal biparietal diameter: a critical re-evaluation of the relation to menstrual age by means of real-time ultrasound. J Ultrasound Med 1982;1:97-104.
10. Jensen JT, Harvey SM, Beckman LJ. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Am J Obstet Gynecol 2000;182:1292-1299.
11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice. Available at: http://www.ich.org/MediaServer.jser?@_ID=482&@_MODE=GLB. Accessed: November 21, 2003.
12. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194.
13. Creinin MD. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception 2000;62:117-124.
14. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 2002;17:92-98.
15. Phillips K, Berry C, Mathers AM. Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin. Eur J Obstet Gynecol Reprod Biol 1996;65:175-176.
16. Sanchez-Ramos L, Kaunitz AM. Uterine rupture associated with the use of prostaglandin E1 in patients with previous cesarean delivery. Am J Obstet Gynecol 2000;182:990-991.
17. Dickinson JE, Godfrey M, Evans SF. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 1998;7:115-119.
18. Wong KS, Ngai CS, Yeo EL, Tang LC, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15:709-712.
19. Wong KS, Ngai CS, Wong AY, Tang LC, Ho PC. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception 1998;58:207-210.
20. Morgan M, Stokes H. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption. Br J Obstet Gynaecol 2000;107:145-146.
21. Fong YF, Singh K, Prasad RN. Severe hyperthermia following use of vaginal misoprostol for pre-operative cervical priming. Int J Gynaecol Obstet 1999;64:73-74.
22. Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002;187:853-857.
23. Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993;307:714-717.
24. Tietze C, Lewit S. Joint Program for the Study of Abortion (JPSA): early medical complications of legal abortion. Stud Fam Plann 1972;3:97-122.
25. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA 1989;262:3143-3147.